Companies Encompass Health
Encompass Health (EHC): executive pay, fiscal 2025
Free brief. Every figure links to the company’s own filing.
Velarion Intel: free for 3 days, no card →Email me Encompass Health’s executive pay brief as a PDF
You get it on this page the moment you ask, and a copy by email. Every figure is cited to its filing.
After the PDF, up to three short notes on the deeper reports for this company. Reply “unsubscribe” to any of them, any time.
CEO vs. named peers39th pct.Of 20 peer CEOs
CEO pay, last three years
- $8,836,376FY2023
- $9,301,929FY2024
- $10,297,258FY2025
CEO total pay was $10,297,258 in fiscal 2025, up from $9,301,929 in fiscal 2024.
FY2025: salary $1,100,000 · bonus $0 · stock awards $5,285,381 · option awards $1,165,376
Executives and directors
Elissa Charbonneau · Chief Medical OfficerDouglas Coltharp · CFOMark Tarr · CEOPatrick Darby · General CounselPatrick Tuer · COOCain A. Hayes · Independent DirectorChristopher R. Reidy · Independent DirectorEdward M. Christie III · Independent DirectorGreg D. Carmichael · Chair of the BoardJoan E. Herman · Independent DirectorKevin J. O'Connor · Independent DirectorLeslye G. Katz · Independent DirectorNancy M. Schlichting · Independent DirectorPatricia A. Maryland · Former director (through FY2025)Terrance Williams · Independent Director
Frequently asked questions
Who was the highest-paid executive at Encompass Health in fiscal 2025?
As disclosed, Mark Tarr (President and Chief Executive Officer) was the highest-paid executive at Encompass Health in fiscal 2025, with total compensation of $10,297,258.
How does Encompass Health's chief executive pay compare to its disclosed peer group?
As disclosed, Mark Tarr's total compensation ranked at the 39th percentile of Encompass Health's disclosed peer group.
What is Encompass Health's CEO-to-median employee pay ratio?
As disclosed, Encompass Health's CEO-to-median employee pay ratio was 203:1.
How did shareholders vote on Encompass Health's executive compensation?
As disclosed, 96.52% of shareholders supported Encompass Health's executive compensation in the latest say-on-pay vote.
How much does Encompass Health spend in total on board compensation for fiscal 2025?
As disclosed, Encompass Health reported total board compensation of $2,810,989 for fiscal 2025.
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Full detail
Every table from the filing. Open any section.
Summary compensation table
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Mark Tarr | $1,100,000 | $0 | $5,285,381 | $1,165,376 | $2,581,525 | $0 | $164,976 | $10,297,258 |
| President and Chief Executive Officer | ||||||||
| Douglas Coltharp | 750,000 | 0 | 1,982,088 | 437,007 | 1,303,800 | 0 | 48,276 | 4,521,171 |
| Executive Vice President and Chief Financial Officer | ||||||||
| Patrick Tuer | 550,000 | 0 | 1,425,095 | 0 | 786,861 | 0 | 81,432 | 2,843,388 |
| Executive Vice President and Chief Operating Officer | ||||||||
| Patrick Darby | 625,000 | 0 | 963,693 | 212,463 | 869,200 | 0 | 11,750 | 2,682,106 |
| Executive Vice President, General Counsel and Secretary | ||||||||
| Elissa Charbonneau | 435,000 | 0 | 518,452 | 0 | 453,722 | 0 | 37,409 | 1,444,583 |
| Chief Medical Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
Three-year trend — total compensation per named executive
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Mark Tarr | $10,297,258 | $9,301,929 | $8,836,376 | ↑ +995,329 |
| Douglas Coltharp | 4,521,171 | 3,868,736 | 5,750,370 | ↑ +652,435 |
| Patrick Tuer | 2,843,388 | — | — | — |
| Patrick Darby | 2,682,106 | 2,558,994 | 3,167,110 | ↑ +123,112 |
| Elissa Charbonneau | 1,444,583 | 1,291,587 | 1,298,212 | ↑ +152,996 |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
Incentive-plan design — the Compensation Discussion & Analysis
Provide a competitive rewards program for our senior management that aligns management's interests with those of our long-term stockholders. Correlate compensation with corporate, regional and business unit outcomes by recognizing performance with appropriate levels and forms of awards
| CEO STI target (% of salary) | 135% |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Pay Governance |
| Clawback policy | true |
| Anti-hedging | true |
| Anti-pledging | True |
Equity grants and outstanding awards
Grants of plan-based awards — fiscal year 2025
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| Douglas Coltharp | PSU | 2025-02-20 | 5,127 | 13,672 | — | 27,344 | $1,526,889 |
| Elissa Charbonneau | PSU | 2025-02-20 | 1,090 | 2,908 | — | 5,816 | 324,765 |
| Mark Tarr | PSU | 2025-02-20 | 13,672 | 36,457 | — | 72,914 | 4,071,518 |
| Patrick Darby | PSU | 2025-02-20 | 2,493 | 6,647 | — | 13,294 | 742,337 |
| Patrick Tuer | PSU | 2025-02-20 | 1,538 | 4,102 | — | 8,204 | 458,111 |
| Patrick Tuer | RSU | 2025-02-20 | — | — | 2,735 | — | 273,199 |
| Patrick Darby | OPTION | 2025-03-04 | — | — | 6,032 | — | 212,463 |
| Mark Tarr | OPTION | 2025-03-04 | — | — | 33,086 | — | 1,165,376 |
| Patrick Tuer | RSU | 2025-05-01 | — | — | 5,984 | — | 693,785 |
| Mark Tarr | RSU | 2025-02-20 | — | — | 12,152 | — | 1,213,863 |
| Douglas Coltharp | OPTION | 2025-03-04 | — | — | 12,407 | — | 437,007 |
| Elissa Charbonneau | RSU | 2025-02-20 | — | — | 1,939 | — | 193,687 |
| Patrick Darby | RSU | 2025-02-20 | — | — | 2,216 | — | 221,356 |
| Douglas Coltharp | RSU | 2025-02-20 | — | — | 4,557 | — | 455,199 |
Vehicle mix — grant-date fair value by award type
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| Douglas Coltharp | $455,199 | $1,526,889 | $437,007 | 63.1% |
| Elissa Charbonneau | 193,687 | 324,765 | 0 | 62.6% |
| Mark Tarr | 1,213,863 | 4,071,518 | 1,165,376 | 63.1% |
| Patrick Darby | 221,356 | 742,337 | 212,463 | 63.1% |
| Patrick Tuer | 966,984 | 458,111 | 0 | 32.1% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
Outstanding equity awards at fiscal year-end 2025
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Patrick Darby | RSU | 985 | — | $104,548 |
| Elissa Charbonneau | RSU | 991 | — | 105,185 |
| Patrick Tuer | RSU | 1,140 | — | 121,000 |
| Elissa Charbonneau | RSU | 1,660 | — | 176,192 |
| Patrick Darby | RSU | 1,875 | — | 199,013 |
| Elissa Charbonneau | RSU | 1,939 | — | 205,806 |
| Douglas Coltharp | RSU | 2,089 | — | 221,726 |
| Patrick Darby | RSU | 2,216 | — | 235,206 |
| Patrick Tuer | RSU | 2,454 | — | 260,467 |
| Patrick Tuer | RSU | 2,735 | — | 290,293 |
| Patrick Darby | Option | 2,897 | 56.21 | — |
| Douglas Coltharp | RSU | 3,499 | — | 371,384 |
| Douglas Coltharp | RSU | 4,557 | — | 483,680 |
| Patrick Darby | Option | 5,263 | 74.2 | — |
| Mark Tarr | RSU | 5,609 | — | 595,339 |
| Elissa Charbonneau | PSU | 5,816 | — | 617,310 |
| Patrick Tuer | RSU | 5,984 | — | 635,142 |
| Patrick Darby | Option | 6,032 | 98.45 | — |
| Douglas Coltharp | Option | 6,144 | 56.21 | — |
| Elissa Charbonneau | PSU | 7,468 | — | 792,654 |
| Patrick Tuer | PSU | 8,204 | — | 870,772 |
| Elissa Charbonneau | PSU | 8,914 | — | 946,132 |
| Douglas Coltharp | Option | 9,824 | 74.2 | — |
| Mark Tarr | RSU | 9,860 | — | 1,046,540 |
| Patrick Tuer | PSU | 10,254 | — | 1,088,360 |
| Patrick Tuer | PSU | 11,040 | — | 1,171,786 |
| Mark Tarr | RSU | 12,152 | — | 1,289,813 |
| Douglas Coltharp | Option | 12,407 | 98.45 | — |
| Patrick Darby | PSU | 13,294 | — | 1,411,025 |
| Patrick Darby | RSU | 14,774 | — | 1,568,112 |
| Mark Tarr | Option | 16,500 | 56.21 | — |
| Patrick Darby | PSU | 16,868 | — | 1,790,370 |
| Patrick Darby | PSU | 17,720 | — | 1,880,800 |
| Douglas Coltharp | PSU | 27,344 | — | 2,902,292 |
| Mark Tarr | Option | 27,683 | 74.2 | — |
| Douglas Coltharp | RSU | 31,321 | — | 3,324,411 |
| Douglas Coltharp | PSU | 31,486 | — | 3,341,924 |
| Mark Tarr | Option | 33,086 | 98.45 | — |
| Douglas Coltharp | PSU | 37,588 | — | 3,989,591 |
| Mark Tarr | PSU | 72,914 | — | 7,739,092 |
| Mark Tarr | PSU | 88,730 | — | 9,417,802 |
| Mark Tarr | PSU | 100,946 | — | 10,714,409 |
Director compensation
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Greg D. CarmichaelIndependent · Board Chair · Compensation and Human Capital | $260,000 | $165,099 | $0 | $0 | $10,112 | $435,211 |
| Leslye G. KatzIndependent · Audit · Nominating/Corporate Governance (Chair) | 130,000 | 165,099 | 0 | 0 | 32,510 | 327,609 |
| Christopher R. ReidyIndependent · Audit (Chair) · Nominating/Corporate Governance | 140,000 | 165,099 | 0 | 0 | 6,834 | 311,933 |
| Nancy M. SchlichtingIndependent · Compensation and Human Capital · Compliance/Quality of Care (Chair) | 130,000 | 165,099 | 0 | 0 | 14,474 | 309,573 |
| Joan E. HermanIndependent · Compensation and Human Capital · Compliance/Quality of Care | 110,000 | 165,099 | 0 | 0 | 32,510 | 307,609 |
| Kevin J. O'ConnorIndependent · Compensation and Human Capital (Chair) · Compliance/Quality of Care | 115,000 | 165,099 | 0 | 0 | 5,981 | 286,080 |
| Terrance WilliamsIndependent · Audit | 110,000 | 165,099 | 0 | 0 | 10,112 | 285,211 |
| Edward M. Christie IIIIndependent · Audit | 110,000 | 165,099 | 0 | 0 | 2,797 | 277,896 |
| Patricia A. MarylandIndependent · Departed during FY | 97,500 | 165,099 | 0 | 0 | 7,268 | 269,867 |
| Cain A. HayesIndependent · Compensation and Human Capital · Compliance/Quality of Care · Partial-year service · Newly elected | 0 | 0 | 0 | 0 | 0 | 0 |
| Mark J. TarrEmployee director | 0 | 0 | 0 | — | 0 | 0 |
Board fee structure and ownership guideline
| Annual cash retainer | $110,000 |
|---|---|
| Annual equity retainer | $165,000 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 30,000 / 20,000 / 20,000 |
| Stock ownership guideline | $550,000 |
Total cost of the board
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $1,202,500 |
| Equity awards (grant-date value) | $1,485,891 |
| All other compensation | $122,598 |
| Total cost of the board | $2,810,989 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Peer group, and who names Encompass Health as a peer
Companies that benchmark against EHC
15 companies name EHC as a compensation peer
The list of companies that name EHC as a peer is temporarily unavailable — recheck shortly.
Disclosed peer group — fiscal year 2025
The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.
BKD Brookdale Senior LivingPACS PACS GroupAMED AmedisysMODV ModivCareRCM R1 RCMCHE ChemedACHC Acadia HealthcareCYH Community Health SystemsSEM Select Medical HoldingsAGL Agilon healthALHC Alignment HealthcareAMN AMN HealthcareDVA DaVitaENSG Ensign GroupLH Labcorp HoldingsOPCH Option Care HealthDGX Quest DiagnosticsSGRY Surgery PartnersUHS Universal Health ServicesBTSG BrightSpring Health Services
Peer reciprocity
The companies Encompass Health names as compensation peers that name it back in their own disclosed peer groups.
Brookdale Senior Living (BKD)113ModivCare (MODV)114Chemed (CHE)115Acadia Healthcare (ACHC)116Community Health Systems (CYH)117AMN Healthcare (AMN)118DaVita (DVA)119Ensign Group (ENSG)120Option Care Health (OPCH)121Surgery Partners (SGRY)122Universal Health Services (UHS)123BrightSpring Health Services (BTSG)124
Chief executive pay against the peer group
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company’s own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Labcorp Holdings | 2025 | Adam Schechter | $1,435,000 | $11,400,463 | $2,754,582 | $2,062,095 | $18,339,913 |
| 2 | DaVita | 2025 | Javier Rodriguez | 1,500,000 | 11,442,481 | 2,699,982 | 2,089,491 | 18,210,597 |
| 3 | BrightSpring Health Services | 2025 | Jon Rousseau | 1,316,717 | 6,000,015 | 5,999,997 | 3,893,750 | 17,841,460 |
| 4 | Pacs Group | 2025 | Jason Murray | 500,000 | 8,358,504 | 0 | 7,272,332 | 17,071,124 |
| 5 | Universal Health Services | 2025 | Marc Miller | 1,430,769 | 9,999,904 | 0 | 4,292,307 | 16,148,937 |
| 6 | Quest Diagnostics | 2025 | James Davis | 1,250,000 | 8,762,861 | 2,999,873 | 2,205,844 | 15,498,479 |
| 7 | R1 RCM | 2023 | Lee Rivas | 900,000 | 12,240,021 | 0 | 1,015,200 | 14,159,376 |
| 8 | Ensign Group | 2025 | Barry Port | 549,264 | 2,912,355 | 0 | 10,317,247 | 13,804,700 |
| 9 | Chemed | 2025 | Kevin McNamara | 1,858,792 | 2,883,553 | 5,036,021 | 1,486,976 | 12,904,720 |
| 10 | Alignment Healthcare | 2025 | John Kao | 833,654 | 8,500,014 | 0 | 1,944,495 | 11,278,583 |
| 11 | AMN Healthcare | 2025 | Cary Grace | 1,060,000 | 8,363,117 | 0 | 1,146,125 | 10,669,780 |
| 12 | Encompass Health | 2025 | Mark Tarr | 1,100,000 | 5,285,381 | 1,165,376 | 2,581,525 | 10,297,258 |
| 13 | Option Care Health | 2025 | John Rademacher | 1,000,000 | 6,500,050 | 0 | 1,665,000 | 9,266,330 |
| 14 | Acadia Healthcare | 2025 | Christopher Hunter | 1,061,000 | 5,712,012 | 0 | 1,135,270 | 7,909,463 |
| 15 | Surgery Partners | 2025 | J. Eric Evans | 1,050,000 | 5,000,000 | 0 | 0 | 6,083,862 |
| 16 | Agilon health | 2025 | Jeffrey Schwaneke | 625,000 | 2,950,003 | 1,750,000 | 271,875 | 5,610,878 |
| 17 | Brookdale Senior Living | 2025 | Nikolas Stengle | 229,310 | 4,283,968 | 0 | 403,571 | 5,307,655 |
| 18 | Community Health Systems | 2025 | Kevin Hammons | 927,194 | 812,700 | 204,300 | 1,746,642 | 4,772,869 |
| 19 | Select Medical Holdings | 2025 | Thomas Mullin | 618,000 | 1,425,000 | 0 | 939,360 | 3,042,527 |
| 20 | ModivCare | 2024 | L. Heath Sampson | 792,885 | 1,685,011 | 0 | 0 | 2,520,122 |
| — | Amedisys | — | — | — | — | — | — | not in coverage universe |
Each peer’s compensation is from its most recently filed proxy; fiscal years differ by company. Each peer’s figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Incentive design against the same peers
| Company | Annual incentive payout | Long-term vehicle mix | PSU measures include TSR | Compensation consultant |
|---|---|---|---|---|
| Encompass Health | 173.8% | PSU 60 · RSU 20 · Options 20 | No | Pay Governance |
| Acadia Healthcare | 85.6% | PSU 50 · RSU 50 | No | WTW |
| Agilon health | 58% | not disclosed | No | Semler Brossy |
| Alignment Healthcare | 200% | not disclosed | No | FW Cook |
| Amedisys | not disclosed | not disclosed | not disclosed | not disclosed |
| AMN Healthcare | 87% | not disclosed | Yes — Relative TSR | FW Cook |
| BrightSpring Health Services | not disclosed | not disclosed | not disclosed | Meridian Compensation Partners |
| Brookdale Senior Living | 125.7% | not disclosed | No | F.W. Cook & Co., Inc. |
| Chemed | not disclosed | not disclosed | Yes — 3-Year Relative Total Shareholder Return (TSR) | Compensation Strategies, Inc. |
| Community Health Systems | not disclosed | PSU 75 · Option 25 | not disclosed | Mercer |
| DaVita | 93% | PSU 60 · RSU 20 · Options 20 | Yes — Relative TSR v. S&P Health Care Services Select Industry Index | Compensia |
| Ensign Group | not disclosed | not disclosed | not disclosed | Willis Towers Watson |
| Labcorp Holdings | 95.8% | PSU 60 · RSU 20 · Options 20 | Yes — RELATIVE TSR MODIFIER | FW Cook |
| ModivCare | not disclosed | PRSU 60 · RSU 40 | not disclosed | Meridian Compensation Partners, LLC |
| Option Care Health | 111% | PSU 60 · RSU 40 | No | Pearl Meyer |
| Pacs Group | not disclosed | RSU 100 | not disclosed | Pearl Meyer |
| Quest Diagnostics | 113.9% | PSU 50 · RSU 25 · Options 25 | Yes — Relative TSR | Semler Brossy |
| R1 RCM | 94% | PSU 75 · RSU 25 | No | SullivanCotter |
| Select Medical Holdings | 190% | RSU 100 | not disclosed | not disclosed |
| Surgery Partners | not disclosed | PSU 60 · Restricted Stock 40 | No | Frederic W. Cook & Co., Inc. (FW Cook) |
| Universal Health Services | 200% | RSU 50 · PSU 50 | No | FW Cook |
Read from each company’s Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company’s filing does not state the item.
Say-on-pay history and pay ratio
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2026 | 2026-05-07 | 83,410,829 | 3,006,776 | 102,636 | 96.52% | Passed |
| 2025 | 2025-05-01 | 87,426,450 | 2,187,504 | 342,779 | 97.56% | Passed |
| 2024 | 2024-05-02 | 87,432,847 | 1,824,905 | 859,438 | 97.02% | Passed |
| 2023 | 2023-05-04 | 82,107,798 | 5,282,269 | 136,695 | 93.81% | Passed |
| 2022 | 2022-05-05 | 83,468,011 | 4,073,770 | 66,352 | 95.27% | Passed |
| 2021 | 2021-05-06 | 81,575,257 | 3,257,385 | 48,896 | 96.1% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year’s compensation.
Say-on-pay — history, company’s computation
| Meeting year | Meeting date | Approval — company’s computation |
|---|---|---|
| 2026 | 2026-05-07 | 96.52%a |
| 2025 | 2025-05-01 | 97.56%b |
| 2024 | 2024-05-02 | 97.02%c |
a. Voting standard not stated in the filing.
b. Voting standard not stated in the filing.
c. Approved under the standard stated in the filing — “Under applicable Delaware law, in determining whether any stockholder proposal has received the requisite number of affirmative votes, abstentions will have the same effect as a vote against any stockholder proposal.”.
Approval percentages are the company’s own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
CEO pay ratio
| Ratio (CEO : median employee) | 203 : 1 |
|---|---|
| CEO total compensation | $10,297,258 |
| Median employee compensation | $50,647 |
Insider trades since the proxy
Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Terrance Williams | Director | 2026-04-15 | A | 27 | $0 | $0 | Common | Form 4 ↗ |
| Nancy M. Schlichting | Director | 2026-04-15 | A | 39 | 0 | 0 | Common | Form 4 ↗ |
| Christopher R. Reidy | Director | 2026-04-15 | A | 19 | 0 | 0 | Common | Form 4 ↗ |
| Kevin J. O'Connor | Director | 2026-04-15 | A | 17 | 0 | 0 | Common | Form 4 ↗ |
| Greg D. Carmichael | Director | 2026-04-15 | A | 27 | 0 | 0 | Common | Form 4 ↗ |
| Joan E. Herman | Director | 2026-04-15 | A | 85 | 0 | 0 | Common | Form 4 ↗ |
| Edward M. Christie III | Director | 2026-04-15 | A | 9 | 0 | 0 | Common | Form 4 ↗ |
| Cain A. Hayes | Director | 2026-04-15 | A | 1 | 0 | 0 | Common | Form 4 ↗ |
| Leslye G. Katz | Director | 2026-04-15 | A | 85 | 0 | 0 | Common | Form 4 ↗ |
| Edward M. Christie III | Director | 2026-04-16 | A | 261 | 106 | 27,710 | Common | Form 4 ↗ |
| Christopher R. Reidy | Director | 2026-04-16 | A | 334 | 106 | 35,564 | Common | Form 4 ↗ |
| Joan E. Herman | Director | 2026-05-07 | A | 1,634 | 0 | 0 | Common | Form 4 ↗ |
| Greg D. Carmichael | Director | 2026-05-07 | A | 1,634 | 0 | 0 | Common | Form 4 ↗ |
| Kevin J. O'Connor | Director | 2026-05-07 | A | 1,634 | 0 | 0 | Common | Form 4 ↗ |
| Christopher R. Reidy | Director | 2026-05-07 | A | 1,634 | 0 | 0 | Common | Form 4 ↗ |
| Nancy M. Schlichting | Director | 2026-05-07 | A | 1,634 | 0 | 0 | Common | Form 4 ↗ |
| Terrance Williams | Director | 2026-05-07 | A | 1,634 | 0 | 0 | Common | Form 4 ↗ |
| Cain A. Hayes | Director | 2026-05-07 | A | 1,634 | 0 | 0 | Common | Form 4 ↗ |
| Edward M. Christie III | Director | 2026-05-07 | A | 1,634 | 0 | 0 | Common | Form 4 ↗ |
| Leslye G. Katz | Director | 2026-05-07 | A | 1,634 | 0 | 0 | Common | Form 4 ↗ |
| Patrick Tuer | EVP, Chief Operating Officer | 2026-05-11 | D | 682 | 105 | 71,310 | Common | Form 4 ↗ |
| Douglas Coltharp | EVP & Chief Financial Officer | 2026-05-15 | D | 27,694 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Douglas Coltharp | EVP & Chief Financial Officer | 2026-05-15 | D | 27,693 | 107 | 2,958,443 | Common | Form 4 ↗ |
| Douglas Coltharp | EVP & Chief Financial Officer | 2026-05-15 | D | 1 | 107 | 107 | Common | Form 4 ↗ |
| Douglas Coltharp | EVP & Chief Financial Officer | 2026-05-15 | A | 27,694 | 33 | 912,240 | Common | Form 4 ↗ |
| Greg D. Carmichael | Director | 2026-07-15 | A | 29 | 0 | 0 | Common | Form 4 ↗ |
| Leslye G. Katz | Director | 2026-07-15 | A | 85 | 0 | 0 | Common | Form 4 ↗ |
| Joan E. Herman | Director | 2026-07-15 | A | 85 | 0 | 0 | Common | Form 4 ↗ |
| Nancy M. Schlichting | Director | 2026-07-15 | A | 40 | 0 | 0 | Common | Form 4 ↗ |
| Edward M. Christie III | Director | 2026-07-15 | A | 11 | 0 | 0 | Common | Form 4 ↗ |
| Christopher R. Reidy | Director | 2026-07-15 | A | 21 | 0 | 0 | Common | Form 4 ↗ |
| Cain A. Hayes | Director | 2026-07-15 | A | 4 | 0 | 0 | Common | Form 4 ↗ |
| Terrance Williams | Director | 2026-07-15 | A | 29 | 0 | 0 | Common | Form 4 ↗ |
| Kevin J. O'Connor | Director | 2026-07-15 | A | 19 | 0 | 0 | Common | Form 4 ↗ |
| Christopher R. Reidy | Director | 2026-07-16 | A | 319 | 112 | 35,856 | Common | Form 4 ↗ |
| Edward M. Christie III | Director | 2026-07-16 | A | 248 | 112 | 27,883 | Common | Form 4 ↗ |
| Patrick Darby | EVP, Gen Counsel & Secretary | 2026-08-10 | D | 8,906 | 126 | 1,121,711 | Common | Form 4 ↗ |
| Mark J. Tarr | Director | 2026-08-10 | D | 1,579 | 126 | 199,049 | Common | Form 4 ↗ |
| Mark J. Tarr | Director | 2026-08-10 | D | 171,569 | 125 | 21,525,047 | Common | Form 4 ↗ |
| Douglas Coltharp | EVP & Chief Financial Officer | 2026-08-10 | D | 18,869 | 125 | 2,365,795 | Common | Form 4 ↗ |
| Patrick Darby | EVP, Gen Counsel & Secretary | 2026-08-31 | D | 4,858 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Patrick Darby | EVP, Gen Counsel & Secretary | 2026-08-31 | D | 4,858 | 121 | 588,255 | Common | Form 4 ↗ |
| Patrick Darby | EVP, Gen Counsel & Secretary | 2026-08-31 | A | 4,858 | 35 | 170,321 | Common | Form 4 ↗ |
| Andrew L. Price | Chief Accounting Officer | 2026-08-31 | D | 5,211 | 121 | 630,166 | Common | Form 4 ↗ |
| Nancy M. Schlichting | Director | 2026-10-15 | A | 38 | 0 | 0 | Common | Form 4 ↗ |
| Terrance Williams | Director | 2026-10-15 | A | 28 | 0 | 0 | Common | Form 4 ↗ |
| Cain A. Hayes | Director | 2026-10-15 | A | 4 | 0 | 0 | Common | Form 4 ↗ |
| Joan E. Herman | Director | 2026-10-15 | A | 81 | 0 | 0 | Common | Form 4 ↗ |
| Edward M. Christie III | Director | 2026-10-15 | A | 11 | 0 | 0 | Common | Form 4 ↗ |
| Leslye G. Katz | Director | 2026-10-15 | A | 81 | 0 | 0 | Common | Form 4 ↗ |
| Greg D. Carmichael | Director | 2026-10-15 | A | 28 | 0 | 0 | Common | Form 4 ↗ |
| Christopher R. Reidy | Director | 2026-10-15 | A | 20 | 0 | 0 | Common | Form 4 ↗ |
| Kevin J. O'Connor | Director | 2026-10-15 | A | 18 | 0 | 0 | Common | Form 4 ↗ |
| Edward M. Christie III | Director | 2026-10-19 | A | 221 | 127 | 27,985 | Common | Form 4 ↗ |
| Christopher R. Reidy | Director | 2026-10-19 | A | 284 | 127 | 36,037 | Common | Form 4 ↗ |
Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.
Sources (124 citations)
Each figure is listed with the filing it comes from, where it appears in that filing, and the value as printed. Any figure can be independently confirmed against the source.
- Section 01, Mark Tarr. DEF 14A, filed 2026-04-07. Section “Summary Compensation Table” · page 49. As printed: 10,297,258. View filing ↗
- Section 01, Douglas Coltharp. DEF 14A, filed 2026-04-07. Section “Summary Compensation Table” · page 49. As printed: 4,521,171. View filing ↗
- Section 01, Patrick Tuer. DEF 14A, filed 2026-04-07. Section “Summary Compensation Table” · page 49. As printed: 2,843,388. View filing ↗
- Section 01, Patrick Darby. DEF 14A, filed 2026-04-07. Section “Summary Compensation Table” · page 49. As printed: 2,682,106. View filing ↗
- Section 01, Elissa Charbonneau. DEF 14A, filed 2026-04-07. Section “Summary Compensation Table” · page 49. As printed: 1,444,583. View filing ↗
- Section 03, Douglas Coltharp PSU. DEF 14A, filed 2026-04-07. Section “Grants of Plan-Based Awards During 2025” · grants of plan-based awards table. View filing ↗
- Section 03, Elissa Charbonneau PSU. DEF 14A, filed 2026-04-07. Section “Grants of Plan-Based Awards During 2025” · grants of plan-based awards table. View filing ↗
- Section 03, Mark Tarr PSU. DEF 14A, filed 2026-04-07. Section “Grants of Plan-Based Awards During 2025” · grants of plan-based awards table. View filing ↗
- Section 03, Patrick Darby PSU. DEF 14A, filed 2026-04-07. Section “Grants of Plan-Based Awards During 2025” · grants of plan-based awards table. View filing ↗
- Section 03, Patrick Tuer PSU. DEF 14A, filed 2026-04-07. Section “Grants of Plan-Based Awards During 2025” · grants of plan-based awards table. View filing ↗
- Section 03, Patrick Tuer RSU. DEF 14A, filed 2026-04-07. Section “Grants of Plan-Based Awards During 2025” · grants of plan-based awards table. View filing ↗
- Section 03, Patrick Darby OPTION. DEF 14A, filed 2026-04-07. Section “Grants of Plan-Based Awards During 2025” · grants of plan-based awards table. View filing ↗
- Section 03, Mark Tarr OPTION. DEF 14A, filed 2026-04-07. Section “Grants of Plan-Based Awards During 2025” · grants of plan-based awards table. View filing ↗
- Section 03, Patrick Tuer RSU. DEF 14A, filed 2026-04-07. Section “Grants of Plan-Based Awards During 2025” · grants of plan-based awards table. View filing ↗
- Section 03, Mark Tarr RSU. DEF 14A, filed 2026-04-07. Section “Grants of Plan-Based Awards During 2025” · grants of plan-based awards table. View filing ↗
- Section 03, Douglas Coltharp OPTION. DEF 14A, filed 2026-04-07. Section “Grants of Plan-Based Awards During 2025” · grants of plan-based awards table. View filing ↗
- Section 03, Elissa Charbonneau RSU. DEF 14A, filed 2026-04-07. Section “Grants of Plan-Based Awards During 2025” · grants of plan-based awards table. View filing ↗
- Section 03, Patrick Darby RSU. DEF 14A, filed 2026-04-07. Section “Grants of Plan-Based Awards During 2025” · grants of plan-based awards table. View filing ↗
- Section 03, Douglas Coltharp RSU. DEF 14A, filed 2026-04-07. Section “Grants of Plan-Based Awards During 2025” · grants of plan-based awards table. View filing ↗
- Section 07, pay ratio. DEF 14A, filed 2026-04-07. Section “CEO Pay Ratio”. As printed: 203 : 1. View filing ↗
- Section 08, Greg D. Carmichael. DEF 14A, filed 2026-04-07. Section “Director Compensation”. As printed: 435,211. View filing ↗
- Section 08, Leslye G. Katz. DEF 14A, filed 2026-04-07. Section “Director Compensation”. As printed: 327,609. View filing ↗
- Section 08, Christopher R. Reidy. DEF 14A, filed 2026-04-07. Section “Director Compensation”. As printed: 311,933. View filing ↗
- Section 08, Nancy M. Schlichting. DEF 14A, filed 2026-04-07. Section “Director Compensation”. As printed: 309,573. View filing ↗
- Section 08, Joan E. Herman. DEF 14A, filed 2026-04-07. Section “Director Compensation”. As printed: 307,609. View filing ↗
- Section 08, Kevin J. O'Connor. DEF 14A, filed 2026-04-07. Section “Director Compensation”. As printed: 286,080. View filing ↗
- Section 08, Terrance Williams. DEF 14A, filed 2026-04-07. Section “Director Compensation”. As printed: 285,211. View filing ↗
- Section 08, Edward M. Christie III. DEF 14A, filed 2026-04-07. Section “Director Compensation”. As printed: 277,896. View filing ↗
- Section 08, Patricia A. Maryland. DEF 14A, filed 2026-04-07. Section “Director Compensation”. As printed: 269,867. View filing ↗
- Section 08, Cain A. Hayes. DEF 14A, filed 2026-04-07. Section “Director Compensation”. As printed: 0. View filing ↗
- Section 08, Mark J. Tarr. DEF 14A, filed 2026-04-07. Section “Director Compensation”. As printed: 0. View filing ↗
- Section 02, Terrance Williams 2026-04-15. Form 4, filed 2026-04-16. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Nancy M. Schlichting 2026-04-15. Form 4, filed 2026-04-16. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Christopher R. Reidy 2026-04-15. Form 4, filed 2026-04-16. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Kevin J. O'Connor 2026-04-15. Form 4, filed 2026-04-16. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Greg D. Carmichael 2026-04-15. Form 4, filed 2026-04-16. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Joan E. Herman 2026-04-15. Form 4, filed 2026-04-16. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Edward M. Christie III 2026-04-15. Form 4, filed 2026-04-16. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Cain A. Hayes 2026-04-15. Form 4, filed 2026-04-16. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Leslye G. Katz 2026-04-15. Form 4, filed 2026-04-16. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Edward M. Christie III 2026-04-16. Form 4, filed 2026-04-16. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Christopher R. Reidy 2026-04-16. Form 4, filed 2026-04-16. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Joan E. Herman 2026-05-07. Form 4, filed 2026-05-11. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Greg D. Carmichael 2026-05-07. Form 4, filed 2026-05-11. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Kevin J. O'Connor 2026-05-07. Form 4, filed 2026-05-11. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Christopher R. Reidy 2026-05-07. Form 4, filed 2026-05-11. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Nancy M. Schlichting 2026-05-07. Form 4, filed 2026-05-11. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Terrance Williams 2026-05-07. Form 4, filed 2026-05-11. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Cain A. Hayes 2026-05-07. Form 4, filed 2026-05-11. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Edward M. Christie III 2026-05-07. Form 4, filed 2026-05-11. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Leslye G. Katz 2026-05-07. Form 4, filed 2026-05-11. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Patrick Tuer 2026-05-11. Form 4, filed 2026-05-12. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Douglas Coltharp 2026-05-15. Form 4, filed 2026-05-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Douglas Coltharp 2026-05-15. Form 4, filed 2026-05-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Douglas Coltharp 2026-05-15. Form 4, filed 2026-05-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Douglas Coltharp 2026-05-15. Form 4, filed 2026-05-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Greg D. Carmichael 2026-07-15. Form 4, filed 2026-07-16. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Leslye G. Katz 2026-07-15. Form 4, filed 2026-07-16. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Joan E. Herman 2026-07-15. Form 4, filed 2026-07-16. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Nancy M. Schlichting 2026-07-15. Form 4, filed 2026-07-16. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Edward M. Christie III 2026-07-15. Form 4, filed 2026-07-16. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Christopher R. Reidy 2026-07-15. Form 4, filed 2026-07-16. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Cain A. Hayes 2026-07-15. Form 4, filed 2026-07-16. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Terrance Williams 2026-07-15. Form 4, filed 2026-07-16. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Kevin J. O'Connor 2026-07-15. Form 4, filed 2026-07-16. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Christopher R. Reidy 2026-07-16. Form 4, filed 2026-07-16. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Edward M. Christie III 2026-07-16. Form 4, filed 2026-07-16. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Patrick Darby 2026-08-10. Form 4, filed 2026-08-11. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mark J. Tarr 2026-08-10. Form 4, filed 2026-08-11. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mark J. Tarr 2026-08-10. Form 4, filed 2026-08-11. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Douglas Coltharp 2026-08-10. Form 4, filed 2026-08-11. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Patrick Darby 2026-08-31. Form 4, filed 2026-09-01. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Patrick Darby 2026-08-31. Form 4, filed 2026-09-01. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Patrick Darby 2026-08-31. Form 4, filed 2026-09-01. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Andrew L. Price 2026-08-31. Form 4, filed 2026-09-01. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Nancy M. Schlichting 2026-10-15. Form 4, filed 2026-10-19. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Terrance Williams 2026-10-15. Form 4, filed 2026-10-19. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Cain A. Hayes 2026-10-15. Form 4, filed 2026-10-19. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Joan E. Herman 2026-10-15. Form 4, filed 2026-10-19. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Edward M. Christie III 2026-10-15. Form 4, filed 2026-10-19. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Leslye G. Katz 2026-10-15. Form 4, filed 2026-10-19. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Greg D. Carmichael 2026-10-15. Form 4, filed 2026-10-19. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Christopher R. Reidy 2026-10-15. Form 4, filed 2026-10-19. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Kevin J. O'Connor 2026-10-15. Form 4, filed 2026-10-19. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Edward M. Christie III 2026-10-19. Form 4, filed 2026-10-19. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Christopher R. Reidy 2026-10-19. Form 4, filed 2026-10-19. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 06, 2026 vote. Form 8-K, filed 2026-05-11. Item 5.07 · say-on-pay result. As reported: 96.52% (votes for as printed: 83,410,829). View filing ↗
- Section 06, 2025 vote. Form 8-K, filed 2025-05-02. Item 5.07 · say-on-pay result. As reported: 97.56% (votes for as printed: 87,426,450). View filing ↗
- Section 06, 2024 vote. Form 8-K, filed 2024-05-06. Item 5.07 · say-on-pay result. As reported: 97.02% (votes for as printed: 87,432,847). View filing ↗
- Section 01 trend, Δ column (computed). Computed. Δ = current-FY total − prior-FY total per named officer.
- Section 03b vehicle mix (computed). Computed. RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).
- Section 09b board cost (computed). Computed. Cash 1,202,500 + equity 1,485,891 + all other 122,598 = 2,810,989, summed across the director compensation table rows.
- Labcorp Holdings, Section 10b CEO total. DEF 14A, filed 2026-04-10. CEO total compensation as printed in Labcorp Holdings's own proxy. As printed: 18,339,913. View filing ↗
- DaVita, Section 10b CEO total. DEF 14A, filed 2026-04-22. CEO total compensation as printed in DaVita's own proxy. As printed: 18,210,597. View filing ↗
- BrightSpring Health Services, Section 10b CEO total. DEF 14A, filed 2026-04-10. CEO total compensation as printed in BrightSpring Health Services's own proxy. As printed: 17,841,460. View filing ↗
- Pacs Group, Section 10b CEO total. DEF 14A, filed 2026-04-28. CEO total compensation as printed in Pacs Group's own proxy. As printed: 17,071,124. View filing ↗
- Universal Health Services, Section 10b CEO total. DEF 14A, filed 2026-04-09. CEO total compensation as printed in Universal Health Services's own proxy. As printed: 16,148,937. View filing ↗
- Quest Diagnostics, Section 10b CEO total. DEF 14A, filed 2026-04-06. CEO total compensation as printed in Quest Diagnostics's own proxy. As printed: 15,498,479. View filing ↗
- R1 RCM, Section 10b CEO total. DEF 14A, filed 2024-04-12. CEO total compensation as printed in R1 RCM's own proxy. As printed: 14,159,376. View filing ↗
- Ensign Group, Section 10b CEO total. DEF 14A, filed 2026-04-02. CEO total compensation as printed in Ensign Group's own proxy. As printed: 13,804,700. View filing ↗
- Chemed, Section 10b CEO total. DEF 14A, filed 2026-04-09. CEO total compensation as printed in Chemed's own proxy. As printed: 12,904,720. View filing ↗
- Alignment Healthcare, Section 10b CEO total. DEF 14A, filed 2026-04-24. CEO total compensation as printed in Alignment Healthcare's own proxy. As printed: 11,278,583. View filing ↗
- AMN Healthcare, Section 10b CEO total. DEF 14A, filed 2026-03-18. CEO total compensation as printed in AMN Healthcare's own proxy. As printed: 10,669,780. View filing ↗
- Encompass Health (subject), Section 10b CEO total. DEF 14A, filed 2026-04-07. CEO total compensation as printed in Encompass Health's own proxy. As printed: 10,297,258. View filing ↗
- Option Care Health, Section 10b CEO total. DEF 14A, filed 2026-04-08. CEO total compensation as printed in Option Care Health's own proxy. As printed: 9,266,330. View filing ↗
- Acadia Healthcare, Section 10b CEO total. DEF 14A, filed 2026-03-25. CEO total compensation as printed in Acadia Healthcare's own proxy. As printed: 7,909,463. View filing ↗
- Surgery Partners, Section 10b CEO total. DEF 14A, filed 2026-04-23. CEO total compensation as printed in Surgery Partners's own proxy. As printed: 6,083,862. View filing ↗
- Agilon health, Section 10b CEO total. DEF 14A, filed 2026-04-22. CEO total compensation as printed in Agilon health's own proxy. As printed: 5,610,878. View filing ↗
- Brookdale Senior Living, Section 10b CEO total. DEF 14A, filed 2026-04-30. CEO total compensation as printed in Brookdale Senior Living's own proxy. As printed: 5,307,655. View filing ↗
- Community Health Systems, Section 10b CEO total. DEF 14A, filed 2026-04-02. CEO total compensation as printed in Community Health Systems's own proxy. As printed: 4,772,869. View filing ↗
- Select Medical Holdings, Section 10b CEO total. DEF 14A, filed 2026-03-04. CEO total compensation as printed in Select Medical Holdings's own proxy. As printed: 3,042,527. View filing ↗
- ModivCare, Section 10b CEO total. DEF 14A, filed 2025-04-30. CEO total compensation as printed in ModivCare's own proxy. As printed: 2,520,122. View filing ↗
- Section 10a, Brookdale Senior Living reciprocity. DEF 14A. Brookdale Senior Living names Encompass Health in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, ModivCare reciprocity. DEF 14A. ModivCare names Encompass Health in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Chemed reciprocity. DEF 14A. Chemed names Encompass Health in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Acadia Healthcare reciprocity. DEF 14A. Acadia Healthcare names Encompass Health in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Community Health Systems reciprocity. DEF 14A. Community Health Systems names Encompass Health in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, AMN Healthcare reciprocity. DEF 14A. AMN Healthcare names Encompass Health in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, DaVita reciprocity. DEF 14A. DaVita names Encompass Health in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Ensign Group reciprocity. DEF 14A. Ensign Group names Encompass Health in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Option Care Health reciprocity. DEF 14A. Option Care Health names Encompass Health in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Surgery Partners reciprocity. DEF 14A. Surgery Partners names Encompass Health in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Universal Health Services reciprocity. DEF 14A. Universal Health Services names Encompass Health in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, BrightSpring Health Services reciprocity. DEF 14A. BrightSpring Health Services names Encompass Health in its own disclosed peer group (read from its most recent proxy). View filing ↗